[Effect of fibrinolysis inhibitors on tissue changes produced by hexadimethrinbromide].
D000311:Adrenal Glands / Q000473:pathology; D000588:Amines / Q000494:pharmacology*; D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D004357:Drug Synergism; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D009336:Necrosis; D010902:Pituitary Gland / Q000187:drug effects* / Q000473:pathology; D051381:Rats
D000588:Amines; D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D001565:Benzoates
Einfluss von Fibrinolyse-Inhibitoren auf die durch Hexadimethrinbromid verursachten Gewebsveränderungen.